MTOR and osteosarcoma: These findings were in accordance with those of previous studies, in which dysregulation of PI3K-AKT-mTOR signaling was associated with osteosarcoma cell proliferation and growth55 and inhibition of the PI3K-AKT pathway suppressed osteosarcoma cell proliferation and growth56.